Treatments for Fragile X Syndrome: A Closer Look at the Data

Autor/in	Hall, Scott S.
Titel	Treatments for Fragile X Syndrome: A Closer Look at the Data
Quelle	In: Developmental Disabilities Research Reviews, 15 (2009) 4, S.353-360 (8 Seiten) PDF als Volltext Verfügbarkeit
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	1940-5510
Schlagwörter	Genetic Disorders; Mental Retardation; Research; Drug Therapy; Behavior Modification; Early Intervention; Children + Suchen Sie Ihr Suchwort? Geistige Behinderung; Forschung; Behaviour modification; Verhaltensänderung; Child; Kind; Kinder
Abstract	Research into the determinants and developmental course of fragile X syndrome (FXS) has made remarkable progress over the last 25 years. However, treatments to ameliorate the symptoms of FXS have been less forthcoming. While there is optimism in the field that the pace of intervention research is quickening, there has been a bias toward psychopharmacological approaches to treatment. A closer look at the data from those investigations reveals a paucity of evidence that medications can improve intellectual and adaptive functioning in FXS, or decrease associated behavioral and/or emotional issues. Work in other related disorders (e.g., autism) has shown that dramatic improvements in intellectual and adaptive functioning, as well as behavioral and emotional problems, can occur if intensive behavioral treatment is begun early in the child's life. It is hoped that future research efforts will evaluate these intensive early intervention strategies in children with FXS, perhaps in combination with pharmacological approaches. (As Provided).
Anmerkungen	Wiley-Blackwell. 111 River Street, Hoboken, NJ 07030-5774. Tel: 800-825-7550; Tel: 201-748-6645; Fax: 201-748-6021; e-mail: subinfo@wiley.com; Web site: http://www3.interscience.wiley.com/browse/?type=JOURNAL
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2017/4/10